Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Insulin Resistance 4Hyperglycemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Leukemia, Myeloid, Acute 1Leukemia 1Intracranial Aneurysm 1Hypoglycemia 1Hyperphagia 1Hyperinsulinism 1Congenital Abnormalities 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 162Radiosurgery 114Radiotherapy 99Bevacizumab 95Magnetic Resonance Spectroscopy 64Carboplatin 48Etoposide 34Surgical Procedures, Operative 33Irinotecan 33pembrolizumab 32Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 29Carmustine 28Cisplatin 25Lomustine 24Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × Insulin × Clear all
NCT00993057 2019-12-13

Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia

Northwestern University

Phase EARLY_PHASE1 Completed
120 enrolled
CNS

Brain Neoplasms, Intracranial Aneurysm, Hypoglycemia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡